Emerald Mutual Fund Advisers Trust United Therapeutics Corp Transaction History

Emerald Mutual Fund Advisers Trust

$1.45 Billion
Q4 2024

A detailed history of Emerald Mutual Fund Advisers Trust transactions in United Therapeutics Corp stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 2,702 shares of UTHR stock, worth $787,308. This represents 0.07% of its overall portfolio holdings.

Number of Shares

2,702

Previous 311 768.81%

Holding current value

$787,308

Previous $111,000 758.56%

% of portfolio

0.07%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$348.66 - $410.0 $833,646 - $980,310	2,391 Added 768.81%	2,702 $953,000
Q3 2024 Oct 29, 2024	BUY	$311.04 - $363.55 $96,733 - $113,064	311 New	311 $111,000
Q2 2023 Aug 10, 2023	SELL	$205.19 - $232.99 $11.4 Million - $12.9 Million	-55,402 Reduced 99.1%	501 $110,000
Q1 2023 May 04, 2023	SELL	$212.99 - $276.17 $2.54 Million - $3.3 Million	-11,935 Reduced 17.59%	55,903 $12.5 Million
Q4 2022 Feb 03, 2023	SELL	$205.95 - $280.43 $7.2 Million - $9.81 Million	-34,979 Reduced 34.02%	67,838 $18.9 Million
Q3 2022 Oct 25, 2022	SELL	$203.3 - $244.17 $6.27 Million - $7.53 Million	-30,846 Reduced 23.08%	102,817 $21.5 Million
Q2 2022 Jul 29, 2022	SELL	$174.81 - $241.14 $7.04 Million - $9.71 Million	-40,277 Reduced 23.16%	133,663 $31.5 Million
Q1 2022 Apr 29, 2022	SELL	$166.16 - $213.96 $2.67 Million - $3.44 Million	-16,083 Reduced 8.46%	173,940 $31.2 Million
Q4 2021 Feb 02, 2022	BUY	$184.32 - $216.08 $1.09 Million - $1.28 Million	5,940 Added 3.23%	190,023 $41.1 Million
Q3 2021 Oct 28, 2021	SELL	$179.86 - $214.88 $37,051 - $44,265	-206 Reduced 0.11%	184,083 $34 Million
Q2 2021 Jul 29, 2021	SELL	$170.47 - $211.93 $374,522 - $465,610	-2,197 Reduced 1.18%	184,289 $33.1 Million
Q1 2021 Apr 29, 2021	BUY	$153.94 - $174.85 $79,586 - $90,397	517 Added 0.28%	186,486 $31.2 Million
Q4 2020 Jan 29, 2021	BUY	$101.87 - $151.79 $1.21 Million - $1.81 Million	11,923 Added 6.85%	185,969 $28.2 Million
Q3 2020 Oct 28, 2020	BUY	$99.9 - $121.13 $20,879 - $25,316	209 Added 0.12%	174,046 $17.6 Million
Q2 2020 Jul 28, 2020	BUY	$92.74 - $125.82 $6.13 Million - $8.31 Million	66,084 Added 61.33%	173,837 $21 Million
Q1 2020 Apr 30, 2020	BUY	$79.39 - $115.35 $8.55 Million - $12.4 Million	107,753 New	107,753 $10.2 Million

Others Institutions Holding UTHR

# of Institutions

728

Shares Held

40.8M

Call Options Held

123K

Put Options Held

104K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $13.3B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.

Account

Emerald Mutual Fund Advisers Trust United Therapeutics Corp Transaction History